Mint Tower Capital Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Mint Tower Capital Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$991K	–	500
2022 Q3	$991K	Hold	100,000	–	–	0.08%	245
2022 Q2	$976K	Hold	100,000	–	–	0.08%	228
2022 Q1	$985K	Hold	100,000	–	–	0.09%	172
2021 Q4	$991K	Hold	100,000	–	–	0.13%	159
2021 Q3	$994K	Hold	100,000	–	–	0.13%	151
2021 Q2	$999K	Buy	100,000 +70,000	+233%	+$701K	0.07%	185
2021 Q1	$302K	Buy	+30,000	New	+$300K	0.03%	268

Other funds holding EBACU

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Mint Tower Capital Management's EBACU Position: Q4 2022 in Review

Mint Tower Capital Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2022, closing a stake of 100,000 shares — an estimated $991K sold.

Mint Tower Capital Management first reported a position in EBACU in Q1 2021 and held it in 7 quarters. The position peaked at $999K in Q2 2021. 11 funds tracked by Wall St. Rank hold EBACU as of Q4 2022.

Mint Tower Capital Management reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
Mint Tower Capital Management sold 100,000 European Biotech Acquisition Corp. Units shares in Q4 2022, an estimated $991K.
Mint Tower Capital Management first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 7 quarters.
Mint Tower Capital Management's European Biotech Acquisition Corp. Units position peaked at $999K in Q2 2021.
11 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2022.

Based on Mint Tower Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.